Get LISNews via email! Enter Your Email Address:
wordy1 writes "The NY Times (registration required) reports: Merck, one of the world's leading pharmaceutical companies, says it supports the idea of a government-run database that
that would keep track of all late-stage clinical drug trials from start to finish. The position by Merck, which the company disclosed in an interview yesterday, is apparently the first major sign of pharmaceutical industry support for such a comprehensive database. Doctors' groups and medical journal publishers have lately called for such a database - or trial registry, as it is also termed - to make it easier to track the results of drug trials. Under the current system of trials, which are typically financed by drug makers, results unfavorable to the companies may never be widely circulated."